FDA published an immediately-in-effect guidance Friday (Sept. 30) laying out a plan to allow certain infant formula products, including those that have been imported into the United States, to remain on the market under FDA’s current enforcement discretion policy in a bid to sustain and diversify the supply of formula available in the United States. The enforcement discretion policy, announced in May , allows certain infant formulas made overseas and intended for a foreign market, or products manufactured domestically and...